Dr. Argyro Athanasiadi, MD, MS

Dr. Athanasiadi practices at Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia.

Dr. Athanasiadi's NPI, 1477073112, was assigned on June 23, 2017. Dr. Athanasiadi holds Georgia license 91574.

Dr. Athanasiadi's primary practice is Wellstar Pulmonary Medicine - HOPD, at 55 Whitcher Street, Marietta, GA 30060.

Dr. Athanasiadi's primary practice is Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia. Dr. Athanasiadi is also affiliated with Wellstar MCG Health Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Athanasiadi to 1 more medical group, named with a free account. Dr. Athanasiadi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Athanasiadi practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Athanasiadi's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Athanasiadi is licensed in Georgia.

CMS data shows 150 Medicare services from Dr. Athanasiadi across 4 procedure codes in 2024, for 81 Medicare patients. Medicare paid $12,276 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 81 Medicare patients who saw Dr. Athanasiadi in 2024. The largest group is under 65, with 30 patients. 75% of them have high blood pressure, and 69% have mood disorders. 52% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Athanasiadi's median patient age at 61, with 67% women.

In 2024, Dr. Athanasiadi wrote 76 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $98 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Athanasiadi for performance year 2024, reported through an alternative payment model (APM). Dr. Athanasiadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Athanasiadi, published from 2018 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Borderline Personality Disorder and Comorbidity. Dr. Athanasiadi has published most often in J Pers Disord. Dr. Athanasiadi's most frequent co-authors are Blaise A. Aguirre, MD, Nithya Cherukuru, MD and Dorothy Chyung.

CMS Open Payments shows 1 general payment to Dr. Athanasiadi from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $22.